Priapism - etiology, pathophysiology and management
- PMID: 15745583
- DOI: 10.1590/s1677-55382003000500002
Priapism - etiology, pathophysiology and management
Abstract
The understanding of erectile physiology has improved the prompt diagnosis and treatment of priapism. Priapism is defined as prolonged and persistent erection of the penis without sexual stimulation and failure to subside despite orgasm. Numerous etiologies of this condition are considered. Among others a disturbed detumescence mechanism, which may due to excess release of contractile neurotransmitters, obstruction of draining venules, malfunction of the intrinsic detumescence mechanism or prolonged relaxation of intracavernosal smooth muscle are postulated. Treatment of priapism varies from a conservative medical to a drastic surgical approach. Two main types of priapism; veno-occlusive low flow (ischemic) and arterial high flow (non-ischemic), must be distinguished to choose the correct treatment option for each type. Patient history, physical examination, penile hemodynamics and corporeal metabolic blood quality provides distinction between a static or dynamic pathology. Priapism can be treated effectively with intracavernous vasoconstrictive agents or surgical shunting. Alternative options, such as intracavernous injection of methylene blue (MB) or selective penile arterial embolization (SPEA), for the management of high and low flow priapism are described and a survey on current treatment modalities is given.
Similar articles
-
New aspects in the treatment of priapism.Andrologia. 1999;31 Suppl 1:53-8. doi: 10.1111/j.1439-0272.1999.tb01451.x. Andrologia. 1999. PMID: 10643520 Review.
-
[Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents].Arch Esp Urol. 2002 Apr;55(3):303-8. Arch Esp Urol. 2002. PMID: 12068762 Clinical Trial. Spanish.
-
Our experience in the treatment of priapism.Cent European J Urol. 2011;64(2):80-3. doi: 10.5173/ceju.2011.02.art6. Epub 2011 Jun 2. Cent European J Urol. 2011. PMID: 24578869 Free PMC article.
-
Priapism.Int J Impot Res. 2000 Oct;12 Suppl 4:S133-9. doi: 10.1038/sj.ijir.3900592. Int J Impot Res. 2000. PMID: 11035401 Review.
-
Arterial embolization in the treatment of post-traumatic priapism.Ann Urol (Paris). 1999;33(3):210-8. Ann Urol (Paris). 1999. PMID: 10417850
Cited by
-
Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling.FASEB J. 2010 Mar;24(3):740-9. doi: 10.1096/fj.09-144147. Epub 2009 Oct 26. FASEB J. 2010. PMID: 19858092 Free PMC article.
-
Stuttering Priapism in a Dog-First Report.Vet Sci. 2022 Sep 23;9(10):518. doi: 10.3390/vetsci9100518. Vet Sci. 2022. PMID: 36288131 Free PMC article.
-
Management of priapism: an update for clinicians.Ther Adv Urol. 2014 Dec;6(6):230-44. doi: 10.1177/1756287214542096. Ther Adv Urol. 2014. PMID: 25435917 Free PMC article. Review.
-
High flow priapism: diagnosis and treatment in pediatric population.Pediatr Surg Int. 2011 Nov;27(11):1217-21. doi: 10.1007/s00383-011-2911-7. Epub 2011 May 5. Pediatr Surg Int. 2011. PMID: 21544645
-
Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.BMC Med. 2018 Apr 25;16(1):59. doi: 10.1186/s12916-018-1045-3. BMC Med. 2018. PMID: 29690878 Free PMC article.
LinkOut - more resources
Full Text Sources
Miscellaneous